rs200407856
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001378615.1(CC2D2A):c.1017+1G>A variant causes a splice donor, intron change. The variant allele was found at a frequency of 0.0000283 in 1,590,166 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001378615.1 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CC2D2A | NM_001378615.1 | c.1017+1G>A | splice_donor_variant, intron_variant | Intron 10 of 36 | ENST00000424120.6 | NP_001365544.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152132Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000467 AC: 10AN: 214102Hom.: 0 AF XY: 0.0000436 AC XY: 5AN XY: 114758
GnomAD4 exome AF: 0.0000216 AC: 31AN: 1437916Hom.: 0 Cov.: 30 AF XY: 0.0000210 AC XY: 15AN XY: 712742
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152250Hom.: 0 Cov.: 33 AF XY: 0.000107 AC XY: 8AN XY: 74436
ClinVar
Submissions by phenotype
Joubert syndrome 9;C2676790:Meckel syndrome, type 6;C5436837:COACH syndrome 2;C5676970:Retinitis pigmentosa 93 Pathogenic:2
- -
- -
not provided Pathogenic:2
- -
Canonical splice site variant predicted to result in a null allele in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 29146704, 22848652, 28497568, 26092869, 22241855) -
Joubert syndrome 9 Pathogenic:2
- -
- -
Meckel-Gruber syndrome;C0431399:Joubert syndrome Pathogenic:1
This sequence change affects a donor splice site in intron 11 of the CC2D2A gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in CC2D2A are known to be pathogenic (PMID: 19777577). This variant is present in population databases (rs200407856, gnomAD 0.04%). Disruption of this splice site has been observed in individual(s) with Joubert syndrome (PMID: 26092869; internal data). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 166801). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
CC2D2A-related disorder Pathogenic:1
The CC2D2A c.1017+1G>A variant is predicted to disrupt the GT donor site and interfere with normal splicing. This variant has been reported along with a second CC2D2A variant in at least one individual with Joubert syndrome (Supplemental Table S5 in Bachmann-Gagescu et al. 2015. PubMed ID: 26092869). This variant is reported in 0.031% of alleles in individuals of African descent in gnomAD. Variants that disrupt the consensus splice donor site in CC2D2A are expected to be pathogenic. This variant is interpreted as likely pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at